However, inhibition of GSK-3β activity has been shown to have positive effects in juvenile but not in adult Cdkl5 KO mice [26], suggesting that pharmacological interventions aimed at normalizing only impaired GSK-3β activity might not be sufficient to restore the defects of a complex disease such as CDD. Here, CDKL5 is linked to craniodiaphyseal dysplasia.